Brand Name | Status | Last Update |
---|---|---|
idamycin pfs | New Drug Application | 2024-01-09 |
idarubicin hydrochloride | ANDA | 2019-12-30 |
Code | Description |
---|---|
J9211 | Injection, idarubicin hydrochloride, 5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 50 | 79 | 43 | 5 | 8 | 153 |
Myelodysplastic syndromes | D009190 | — | D46 | 12 | 19 | 9 | 1 | 3 | 36 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | 7 | 7 | 7 | 2 | 21 |
Promyelocytic leukemia acute | D015473 | — | C92.4 | 2 | 3 | 4 | 4 | 1 | 14 |
Philadelphia chromosome | D010677 | — | — | — | 1 | — | 1 | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | — | 1 | 1 | — | 2 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | — | — | — | 1 | — | 1 |
Burkitt lymphoma | D002051 | — | C83.7 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 14 | 33 | 22 | — | 1 | 60 |
Monocytic leukemia acute | D007948 | — | — | 4 | 6 | 2 | — | 1 | 11 |
Myelomonocytic leukemia acute | D015479 | — | C92.5 | 4 | 5 | 1 | — | 1 | 10 |
Erythroblastic leukemia acute | D004915 | EFO_1001257 | C94.0 | 4 | 5 | 1 | — | 1 | 10 |
Megakaryoblastic leukemia acute | D007947 | — | C94.2 | 3 | 5 | 1 | — | 1 | 9 |
Myeloid leukemia | D007951 | — | C92 | 2 | 6 | 2 | — | 1 | 8 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 3 | 1 | — | 4 | 8 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 3 | 1 | 2 | — | 1 | 6 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 4 | 1 | — | 1 | 6 |
Anemia | D000740 | HP_0001903 | D64.9 | 1 | 3 | 2 | — | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 4 | — | — | — | 5 |
Basophilic leukemia acute | D015471 | — | C94.8 | 1 | 3 | — | — | — | 3 |
Eosinophilic leukemia acute | D015472 | — | — | 1 | 3 | — | — | — | 3 |
Biphenotypic leukemia acute | D015456 | — | C95.0 | 1 | 3 | — | — | — | 3 |
Graft vs host disease | D006086 | — | D89.81 | — | 2 | — | — | — | 2 |
Myeloproliferative disorders | D009196 | — | D47.1 | 1 | 2 | — | — | — | 2 |
Urologic neoplasms | D014571 | — | C64-C68 | — | 1 | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | — | 1 | — | — | — | 1 |
Myeloid sarcoma | D023981 | — | C92.3 | — | 1 | — | — | — | 1 |
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fibrosis | D005355 | — | — | 1 | — | — | — | — | 1 |
Neoplasms by histologic type | D009370 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | — | 1 | 1 |
Drug common name | Idarubicin |
INN | idarubicin |
Description | Idarubicin is a monosaccharide derivative, an anthracycline antibiotic and a deoxy hexoside. It derives from a hydride of a tetracene. |
Classification | Small molecule |
Drug class | antineoplastic antibiotics (daunorubicin type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O |
PDB | — |
CAS-ID | 58957-92-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1117 |
ChEBI ID | 42068 |
PubChem CID | 42890 |
DrugBank | DB01177 |
UNII ID | ZRP63D75JW (ChemIDplus, GSRS) |